Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2012, Article ID 159646, 6 pages
http://dx.doi.org/10.1155/2012/159646
Research Article

Bradykinin Type-2 Receptor Expression Correlates with Age and Is Subjected to Transcriptional Regulation

1Wihuri Research Institute, Kalliolinnantie 4, 00140 Helsinki, Finland
2Department of Cardiology, Jyväskylä Central Hospital, 40620 Jyväskylä, Finland

Received 19 May 2011; Accepted 11 July 2011

Academic Editor: John W. Calvert

Copyright © 2012 Inka Liesmaa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. P. Yang, Y. H. Liu, G. M. Scicli, C. R. Webb, and O. A. Carretero, “Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats,” Hypertension, vol. 30, no. 3, pp. 735–740, 1997. View at Google Scholar · View at Scopus
  2. J. B. Su, F. Barbe, R. Houel, T. T. Guyene, B. Crozatier, and L. Hittinger, “Preserved vasodilator effect of bradykinin in dogs with heart failure,” Circulation, vol. 98, no. 25, pp. 2911–2918, 1998. View at Google Scholar · View at Scopus
  3. K. C. Wollert, R. Studer, K. Doerfer et al., “Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat,” Circulation, vol. 95, no. 7, pp. 1910–1917, 1997. View at Google Scholar · View at Scopus
  4. J. M. Hall, “Bradykinin receptors: pharmacological properties and biological roles,” Pharmacology and Therapeutics, vol. 56, no. 2, pp. 131–190, 1992. View at Google Scholar · View at Scopus
  5. P. Groves, S. Kurz, H. Just, and H. Drexler, “Role of endogenous bradykinin in human coronary vasomotor control,” Circulation, vol. 92, no. 12, pp. 3424–3430, 1995. View at Google Scholar · View at Scopus
  6. B. S. McAllister, F. Leeb-Lundberg, and M. S. Olson, “Bradykinin inhibition of EGF- and PDGF-induced DNA synthesis in human fibroblasts,” American Journal of Physiology, vol. 265, no. 2, pp. C477–C484, 1993. View at Google Scholar · View at Scopus
  7. Y. Ishigai, T. Mori, T. Ikeda, A. Fukuzawa, and T. Shibano, “Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes,” American Journal of Physiology, vol. 273, no. 6, pp. H2659–H2663, 1997. View at Google Scholar · View at Scopus
  8. D. Regoli, D. Jukic, F. Gobeil, and N. E. Rhaleb, “Receptors for bradykinin and related kinins: a critical analysis,” Canadian Journal of Physiology and Pharmacology, vol. 71, no. 8, pp. 556–567, 1993. View at Google Scholar · View at Scopus
  9. E. J. J. Van Zoelen, P. H. J. Peters, G. B. Afink et al., “Bradykinin-induced growth inhibition of normal rat kidney (NRK) cells is paralleled by a decrease in epidermal-growth-factor receptor expression,” Biochemical Journal, vol. 298, no. 2, pp. 335–340, 1994. View at Google Scholar · View at Scopus
  10. A. C. Rosenkranz, G. J. Dusting, and R. H. Ritchie, “Hyperglycaemia abolishes the antihypertrophic efficacy of bradykinin in rat ventricular myocytes,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 7, pp. 519–521, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kuoppala, N. Shiota, J. O. Kokkonen et al., “Down-regulation of cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure,” Journal of the American College of Cardiology, vol. 40, no. 1, pp. 119–125, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. G. N. Prado, L. Taylor, X. Zhou, D. Ricupero, D. F. Mierke, and P. Polgar, “Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors,” Journal of Cellular Physiology, vol. 193, no. 3, pp. 275–286, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. V. Gainer, N. J. Brown, M. Bachvarova et al., “Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans,” American Journal of Hypertension, vol. 13, no. 12, pp. 1268–1273, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Mukae, S. Aoki, S. Itoh et al., “Promoter polymorphism of the β2 bradykinin receptor gene is associated with essential hypertension,” Japanese Circulation Journal, vol. 63, no. 10, pp. 759–762, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Wang, A. Dang, and G. Liu, “Genetic variation in the promoter region of the β2 bradykinin receptor gene is associated with essential hypertension in a Chinese Han population,” Hypertension Research, vol. 24, no. 3, pp. 299–302, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Emanueli, R. Maestri, D. Corradi et al., “Dilated and failing cardiomyopathy in bradykinin B2 receptor knockout mice,” Circulation, vol. 100, no. 23, pp. 2359–2365, 1999. View at Google Scholar · View at Scopus
  17. A. Duka, I. Duka, G. Gao, S. Shenouda, I. Gavras, and H. Gavras, “Role of bradykinin B1 and B2 receptors in normal blood pressure regulation,” American Journal of Physiology, vol. 291, no. 2, pp. E268–E274, 2006. View at Publisher · View at Google Scholar · View at PubMed
  18. D. Brull, S. Dhamrait, S. Myerson et al., “Bradykinin B2BKR receptor polymorphism and left-ventricular growth response,” The Lancet, vol. 358, no. 9288, pp. 1155–1156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Hallberg, L. Lind, K. Michaëlsson et al., “B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial,” Journal of Hypertension, vol. 21, no. 3, pp. 621–624, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Fischer, W. Lieb, D. Marold et al., “Lack of association of a 9 bp insertion/deletion polymorphism within the bradykinin 2 receptor gene with myocardial infarction,” Clinical Science, vol. 107, no. 5, pp. 505–511, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. Kakoki, C. M. Kizer, X. Yi et al., “Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors,” Journal of Clinical Investigation, vol. 116, no. 5, pp. 1302–1309, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. H. Oeseburg, D. Iusuf, P. van der Harst, W. H. van Gilst, R. H. Henning, and A. J. Roks, “Bradykinin protects against oxidative stress-induced endothelial cell senescence,” Hypertension, vol. 53, no. 2, pp. 417–422, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. C. Roffe, “Ageing of the heart,” British Journal of Biomedical Science, vol. 55, no. 2, pp. 136–148, 1998. View at Google Scholar · View at Scopus
  24. E. Kintsurashvili, A. Duka, I. Ignjacev, G. Pattakos, I. Gavras, and H. Gavras, “Age-related changes of bradykinin B1 and B2 receptors in rat heart,” American Journal of Physiology, vol. 289, no. 1, pp. H202–H205, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. A. Kuoppala, N. Shiota, K. A. Lindstedt et al., “Expression of bradykinin receptors in the left ventricles of rats with pressure overload hypertrophy and heart failure,” Journal of Hypertension, vol. 21, no. 9, pp. 1729–1736, 2003. View at Publisher · View at Google Scholar · View at Scopus